AI in Medical Imaging Market Size, Share & Trends Analysis Report By Technology (Deep Learning, NLP), By Application (Neurology, Orthopedics), By End Use (Hospitals, Diagnostic Centers), By Modalities, By Region,- Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2024-2034

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope

1.1.1. Technology

1.1.2. Application

1.1.3. Modalities

1.1.4. End Use

1.1.5. AI-Powered AI in Medical Imaging

1.1.6. Regional scope

1.1.7. Estimates and forecast timeline.

1.2. Research Methodology

1.3. Information Procurement

1.3.1. Purchased database

1.3.2. internal database

1.3.3. Secondary sources

1.3.4. Primary research

1.3.5. Details of primary research

1.4. Information or Data Analysis

1.4.1. Data analysis models

1.5. Market Formulation & Validation

1.6. Model Details

1.6.1. Commodity flow analysis (Model 1)

1.6.2. Approach 1: Commodity flow approach

1.6.3. Volume price analysis (Model 2)

1.6.4. Approach 2: Volume price analysis

1.7. List of Secondary Sources

1.8. List of Primary Sources

1.9. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Outlook

2.2.1. Technology outlook

2.2.2. Application outlook

2.2.3. Modalities outlook

2.2.4. End use outlook

2.2.5. Regional outlook

2.3. Competitive Insights

Chapter 3. AI in Medical Imaging Market Variables, Trends & Scope

3.1. Market Lineage Outlook

3.1.1. Parent market outlook

3.1.2. Related/ancillary market outlook

3.2. Market Dynamics

3.2.1. Market driver analysis

3.2.2. Market restraint analysis

3.3. AI in Medical Imaging Market Analysis Tools

3.3.1. Industry Analysis - Porter’s

3.3.1.1. Supplier power

3.3.1.2. Buyer power

3.3.1.3. Substitution threat

3.3.1.4. Threat of new entrant

3.3.1.5. Competitive rivalry

3.3.2. PESTEL Analysis

3.3.2.1. Political landscape

3.3.2.2. Technological landscape

3.3.2.3. Economic landscape

3.3.3. COVID-19 Impact

Chapter 4. AI in Medical Imaging Market: Technology Estimates & Trend Analysis

4.1. Technology Market Share, 2024 & 2034

4.2. Segment Dashboard

4.3. Global AI in Medical Imaging Market by Technology Outlook

4.4. Deep Learning

4.4.1. Market estimates and forecast 2021 to 2034 (USD Million)

4.5. Natural Language Processing (NLP)

4.5.1. Market estimates and forecast 2021 to 2034 (USD Million)

4.6. Others

4.6.1. Market estimates and forecast 2021 to 2034 (USD Million)

Chapter 5. AI in Medical Imaging Market: Application Estimates & Trend Analysis

5.1. Application Market Share, 2024 & 2034

5.2. Segment Dashboard

5.3. Global AI in Medical Imaging Market by Application Outlook

5.4. Neurology

5.4.1. Market estimates and forecast 2021 to 2034 (USD Million)

5.5. Respiratory and Pulmonary

5.5.1. Market estimates and forecast 2021 to 2034 (USD Million)

5.6. Cardiology

5.6.1. Market estimates and forecast 2021 to 2034 (USD Million)

5.7. Breast Screening

5.7.1. Market estimates and forecast 2021 to 2034 (USD Million)

5.8. Orthopedics

5.8.1. Market estimates and forecast 2021 to 2034 (USD Million)

5.9. Others

5.9.1. Market estimates and forecast 2021 to 2034 (USD Million)

Chapter 6. AI in Medical Imaging Market: Modalities Estimates & Trend Analysis

6.1. Modalities Market Share, 2024 & 2034

6.2. Segment Dashboard

6.3. Global AI in Medical Imaging Market by Modalities Outlook

6.4. CT-Scan

6.4.1. Market estimates and forecast 2021 to 2034 (USD Million)

6.5. MRI

6.5.1. Market estimates and forecast 2021 to 2034 (USD Million)

6.6. X-rays

6.6.1. Market estimates and forecast 2021 to 2034 (USD Million)

6.7. Ultrasound

6.7.1. Market estimates and forecast 2021 to 2034 (USD Million)

6.8. Nuclear Imaging

6.8.1. Market estimates and forecast 2021 to 2034 (USD Million)

Chapter 7. AI in Medical Imaging Market: End Use Estimates & Trend Analysis

7.1. End Use Market Share, 2024 & 2034

7.2. Segment Dashboard

7.3. Global AI in Medical Imaging Market Modalities Outlook

7.4. Hospitals

7.4.1. Market estimates and forecast 2021 to 2034 (USD Million)

7.5. Diagnostic Imaging Centers

7.5.1. Market estimates and forecast 2021 to 2034 (USD Million)

7.6. Others

7.6.1. Market estimates and forecast 2021 to 2034 (USD Million)

Chapter 8. AI in Medical Imaging Market: Regional Estimates & Trend Analysis, By Technology, By Application, By Modalities, End Use, By AI-Powered AI in Medical Imaging

8.1. Regional Market Share Analysis, 2024 & 2034

8.2. Regional Market Dashboard

8.3. Global Regional Market Snapshot

8.4. Market Size, & Forecasts Trend Analysis, 2021 to 2034:

8.5. North America

8.5.1. U.S.

8.5.1.1. Key country dynamics

8.5.1.2. Regulatory framework/ reimbursement structure

8.5.1.3. Competitive scenario

8.5.1.4. U.S. market estimates and forecasts 2021 to 2034 (USD Million)

8.5.2. Canada

8.5.2.1. Key country dynamics

8.5.2.2. Regulatory framework/ reimbursement structure

8.5.2.3. Competitive scenario

8.5.2.4. Canada market estimates and forecasts 2021 to 2034 (USD Million)

8.5.3. Mexico

8.5.3.1. Key country dynamics

8.5.3.2. Regulatory framework/ reimbursement structure

8.5.3.3. Competitive scenario

8.5.3.4. Mexico market estimates and forecasts 2021 to 2034 (USD Million)

8.6. Europe

8.6.1. UK

8.6.1.1. Key country dynamics

8.6.1.2. Regulatory framework/ reimbursement structure

8.6.1.3. Competitive scenario

8.6.1.4. UK market estimates and forecasts 2021 to 2034 (USD Million)

8.6.2. Germany

8.6.2.1. Key country dynamics

8.6.2.2. Regulatory framework/ reimbursement structure

8.6.2.3. Competitive scenario

8.6.2.4. Germany market estimates and forecasts 2021 to 2034 (USD Million)

8.6.3. France

8.6.3.1. Key country dynamics

8.6.3.2. Regulatory framework/ reimbursement structure

8.6.3.3. Competitive scenario

8.6.3.4. France market estimates and forecasts 2021 to 2034 (USD Million)

8.6.4. Italy

8.6.4.1. Key country dynamics

8.6.4.2. Regulatory framework/ reimbursement structure

8.6.4.3. Competitive scenario

8.6.4.4. Italy market estimates and forecasts 2021 to 2034 (USD Million)

8.6.5. Spain

8.6.5.1. Key country dynamics

8.6.5.2. Regulatory framework/ reimbursement structure

8.6.5.3. Competitive scenario

8.6.5.4. Spain market estimates and forecasts 2021 to 2034 (USD Million)

8.6.6. Norway

8.6.6.1. Key country dynamics

8.6.6.2. Regulatory framework/ reimbursement structure

8.6.6.3. Competitive scenario

8.6.6.4. Norway market estimates and forecasts 2021 to 2034 (USD Million)

8.6.7. Sweden

8.6.7.1. Key country dynamics

8.6.7.2. Regulatory framework/ reimbursement structure

8.6.7.3. Competitive scenario

8.6.7.4. Sweden market estimates and forecasts 2021 to 2034 (USD Million)

8.6.8. Denmark

8.6.8.1. Key country dynamics

8.6.8.2. Regulatory framework/ reimbursement structure

8.6.8.3. Competitive scenario

8.6.8.4. Denmark market estimates and forecasts 2021 to 2034 (USD Million)

8.7. Asia Pacific

8.7.1. Japan

8.7.1.1. Key country dynamics

8.7.1.2. Regulatory framework/ reimbursement structure

8.7.1.3. Competitive scenario

8.7.1.4. Japan market estimates and forecasts 2021 to 2034 (USD Million)

8.7.2. China

8.7.2.1. Key country dynamics

8.7.2.2. Regulatory framework/ reimbursement structure

8.7.2.3. Competitive scenario

8.7.2.4. China market estimates and forecasts 2021 to 2034 (USD Million)

8.7.3. India

8.7.3.1. Key country dynamics

8.7.3.2. Regulatory framework/ reimbursement structure

8.7.3.3. Competitive scenario

8.7.3.4. India market estimates and forecasts 2021 to 2034 (USD Million)

8.7.4. Australia

8.7.4.1. Key country dynamics

8.7.4.2. Regulatory framework/ reimbursement structure

8.7.4.3. Competitive scenario

8.7.4.4. Australia market estimates and forecasts 2021 to 2034 (USD Million)

8.7.5. South Korea

8.7.5.1. Key country dynamics

8.7.5.2. Regulatory framework/ reimbursement structure

8.7.5.3. Competitive scenario

8.7.5.4. South Korea market estimates and forecasts 2021 to 2034 (USD Million)

8.7.6. Thailand

8.7.6.1. Key country dynamics

8.7.6.2. Regulatory framework/ reimbursement structure

8.7.6.3. Competitive scenario

8.7.6.4. Thailand market estimates and forecasts 2021 to 2034 (USD Million)

8.8. Latin America

8.8.1. Brazil

8.8.1.1. Key country dynamics

8.8.1.2. Regulatory framework/ reimbursement structure

8.8.1.3. Competitive scenario

8.8.1.4. Brazil market estimates and forecasts 2021 to 2034 (USD Million)

8.8.2. Argentina

8.8.2.1. Key country dynamics

8.8.2.2. Regulatory framework/ reimbursement structure

8.8.2.3. Competitive scenario

8.8.2.4. Argentina market estimates and forecasts 2021 to 2034 (USD Million)

8.9. MEA

8.9.1. South Africa

8.9.1.1. Key country dynamics

8.9.1.2. Regulatory framework/ reimbursement structure

8.9.1.3. Competitive scenario

8.9.1.4. South Africa market estimates and forecasts 2021 to 2034 (USD Million)

8.9.2. Saudi Arabia

8.9.2.1. Key country dynamics

8.9.2.2. Regulatory framework/ reimbursement structure

8.9.2.3. Competitive scenario

8.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2034 (USD Million)

8.9.3. UAE

8.9.3.1. Key country dynamics

8.9.3.2. Regulatory framework/ reimbursement structure

8.9.3.3. Competitive scenario

8.9.3.4. UAE market estimates and forecasts 2021 to 2034 (USD Million)

8.9.4. Kuwait

8.9.4.1. Key country dynamics

8.9.4.2. Regulatory framework/ reimbursement structure

8.9.4.3. Competitive scenario

8.9.4.4. Kuwait market estimates and forecasts 2021 to 2034 (USD Million)

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, By Key Market Participants

9.2. Company/Competition Categorization

9.2.1. Innovators

9.2.2. List of key distributors and channel partners

9.2.3. Key customers

9.2.4. Key company market share analysis, 2023

9.2.5. GE Healthcare

9.2.5.1. Company overview

9.2.5.2. Financial performance

9.2.5.3. Product benchmarking

9.2.5.4. Strategic initiatives

9.2.6. Microsoft

9.2.6.1. Company overview

9.2.6.2. Financial performance

9.2.6.3. Product benchmarking

9.2.6.4. Strategic initiatives

9.2.7. Digital Diagnostics Inc.

9.2.7.1. Company overview

9.2.7.2. Financial performance

9.2.7.3. Product benchmarking

9.2.7.4. Strategic initiatives

9.2.8. Tempus

9.2.8.1. Company overview

9.2.8.2. Financial performance

9.2.8.3. Product benchmarking

9.2.8.4. Strategic initiatives

9.2.9. Butterfly Network Inc.

9.2.9.1. Company overview

9.2.9.2. Financial performance

9.2.9.3. Product benchmarking

9.2.9.4. Strategic initiatives

9.2.10. Advanced Micro Devices, Inc.

9.2.10.1. Company overview

9.2.10.2. Financial performance

9.2.10.3. Product benchmarking

9.2.10.4. Strategic initiatives

9.2.11. Heartflow Inc.

9.2.11.1. Company overview

9.2.11.2. Financial performance

9.2.11.3. Product benchmarking

9.2.11.4. Strategic initiatives

9.2.12. Enlitic, Inc.

9.2.12.1. Company overview

9.2.12.2. Financial performance

9.2.12.3. Product benchmarking

9.2.12.4. Strategic initiatives

9.2.13. Canon Medical Systems, Inc.

9.2.13.1. Company overview

9.2.13.2. Financial performance

9.2.13.3. Product benchmarking

9.2.13.4. Strategic initiatives

9.2.14. Viz.ai, Inc.

9.2.14.1. Company overview

9.2.14.2. Financial performance

9.2.14.3. Product benchmarking

9.2.14.4. Strategic initiatives

9.2.15. EchoNous, Inc.

9.2.15.1. Company overview

9.2.15.2. Financial performance

9.2.15.3. Product benchmarking

9.2.15.4. Strategic initiatives

9.2.16. HeartVista, Inc.

9.2.16.1. Company overview

9.2.16.2. Financial performance

9.2.16.3. Product benchmarking

9.2.16.4. Strategic initiatives

9.2.17. Exo Imaging, Inc.

9.2.17.1. Company overview

9.2.17.2. Financial performance

9.2.17.3. Product benchmarking

9.2.17.4. Strategic initiatives

9.2.18. NANO-X IMAGING LTD

9.2.18.1. Company overview

9.2.18.2. Financial performance

9.2.18.3. Product benchmarking

9.2.18.4. Strategic initiatives